Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).
Literal federal measure citations: H.R. 8999
2025 · 2nd Quarter (Apr 1 - June 30)
KANEKA PHARMA AMERICA, LLC
Filed by KING & SPALDING LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- KING & SPALDING LLP
- Filing UUID
- bf5b8825-8e9f-4a2b-b57b-b62b8dbf0204
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.